Flexion Therapeutics News
Most Popular Flexion Therapeutics Story
Emerging Drug Developer: Flexion Therapeutics
A ruthless pursuit of the bold experiment Mike Clayman and Neil Bodick are no strangers to the development process. Together they founded Chorus, Eli Lilly's in-house, early-stage development group,
Read more...Latest Headlines
- January 29, 2010
- November 16, 2009
- October 19, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
